The novel Coronavirus CoVid-19 outbreak is now consider a world pandemic affecting more than 300000 people worldwide. Cancer patients are in risk for severe disease including a higher risk of intensive care unit ICU admission need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak due to need of multiple hospital visits and admissions immunosuppression and need for chemotherapy radiotherapy and stem cell transplantation. In this article we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic focusing on minimizing the risk for patients. How to manage lymphoid malignancies during novel 2019 coronavirus CoVid-19 outbreak: a Brazilian task force recommendation.